MRPL4 and cancer: Conversely, MRPL genes with consistently established associations between expression and metastasis-related traits across a variety of cancer types (e.g. MRPL4, MRPL35 and MRPL42), are putative prognostic and therapeutic targets as they would have broad applicability across the cancer spectrum, thus directly benefit more patients.